Strategies to improve pharmaceutical supply chain resilience under politico-economic sanctions: the case of Iran

References

• van de Pas R, Ashour M, Kapilashrami A, Fustukian S. Interrogating resilience in health systems development. Health Policy Plan. 2017;32(suppl_3):iii88–iii90.
   Google Scholar
• Yaroson EV, Breen L, Hou J, Sowter J. Resilience strategies and the pharmaceutical supply chain: the role of agility in mitigating drug shortages. In: Pharmaceutical supply chains-medicines shortages. Cham: Springer; 2019. p. 249–256.
   Google Scholar
• Fridell M, Edwin S, Von Schreeb J, Saulnier DD. Health system resilience: what are we talking about? A scoping review mapping characteristics and keywords. Int J Health Policy Manag. 2020;9(1):6–16.
   PubMed Web of Science ®Google Scholar
• Alqudah S, Shrouf H, Suifan T, Alhyari S. A moderated mediation model of lean, agile, resilient, and green paradigms in the supply chain. Int J Sup Chain Mgt. 2020;9(4):1–16.
   Google Scholar
• Bhatia G, Lane C, Wain A, editors. Building resilience in supply chains. World Economic Forum; 2013.
   Google Scholar
• Fox ER, Sweet BV, Jensen V, editors. Drug shortages: a complex health care crisis. Mayo Clin Proc. 2014.
   Web of Science ®Google Scholar
• Pauwels K, Simoens S, Casteels M, Huys I. Insights into European drug shortages: a survey of hospital pharmacists. PLoS ONE. 2015;10(3): e0119322.
   Web of Science ®Google Scholar
• Ghatari AR, Mehralian G, Zarenezhad F, Rasekh HR. Developing a model for agile supply: an empirical study from Iranian pharmaceutical supply chain. Iran J Pharm Res. 2013;12(Suppl):193–205.
   Google Scholar
• Aigbogun O, Ghazali Z, Razali R. A framework to enhance supply chain resilience the case of Malaysian pharmaceutical industry. Glob Bus Manag Res. 2014;6(3):219–228.
   Google Scholar
• Mehralian G, Moosivand A, Emadi S, Asgharian R. Developing a coordination framework for pharmaceutical supply chain: using analytical hierarchy process. Int J Logist Syst Manag. 2017;26(3):277–293.
   Google Scholar
• Chabner BA. Drug shortages—a critical challenge for the generic-drug market. N Engl J Med. 2011;365(23):2147–2149.
   PubMed Web of Science ®Google Scholar
• Abdollahiasl A, Jaberidoost M, Farshchi A. PHP13 affordability of antibacterial medicines in Iran during 2001–2010. Value Health. 2012;15(7):A611.
   Web of Science ®Google Scholar
• Kheirandish M, Rashidian A, Kebriaeezade A, Cheraghali AM, Soleymani F. A review of pharmaceutical policies in response to economic crises and sanctions. J Res Pharm Pract. 2015;4(3):115–122.
   Google Scholar
• Cheraghali AM. Impacts of international sanctions on Iranian pharmaceutical market. Daru. 2013;21(1):64–66.
   PubMedGoogle Scholar
• Aloosh M, Salavati A, Aloosh A. Economic sanctions threaten population health: the case of Iran. Public Health. 2019;169:10–13.
   Web of Science ®Google Scholar
• Guba EG, Lincoln YS. Competing paradigms in qualitative research. In: Lincoln DYS, editor. Handbook of qualitative research. Thousand Oaks: Sage Publications Inc.; 1994. p. 105–117.
   Google Scholar
• Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013;13(1):117–124.
   PubMed Web of Science ®Google Scholar
• Van der Stuyft P, De Vos P, Hiderbrand K. USA and shortage of food and medicine in Cuba. Lancet. 1997;349(9048):363.
   Google Scholar
• World Health Organization. How to develop and implement a national drug policy. 2nd ed. Geneva: World Health Organization; 2001.
   Google Scholar
• Homedes N, Ugalde A. Improving access to pharmaceuticals in Brazil and Argentina. Health Policy Plan. 2006;21(2):123–131.
   PubMed Web of Science ®Google Scholar
• Privett N, Gonsalvez D. The top ten global health supply chain issues: perspectives from the field. Oper Res Health Care. 2014;3(4):226–230.
   Google Scholar
• Roberts MJ, Reich MR. Last mile logistics for essential drugs: the case of Zambia. In: Roberts M, Reich M, editors. Pharmaceutical reform: a guide to improving performance and equity. Washington, DC: World Bank; 2011.
   Google Scholar
• Esmaeillou Y, Asl IM, Tabibi SJ, Majid CA. Identifying factors affecting the pharmaceutical supply chain management in Iran. Galen Med J.. 2017;6(4):346–355.
   Google Scholar
• World Health Organization. Equitable access to essential medicines: a framework for collective action. Geneva: World Health Organization; 2004.
   Google Scholar
• Yu X, Li C, Shi Y, Yu M. Pharmaceutical supply chain in China: current issues and implications for health system reform. Health Policy. 2010;97(1):8–15.
   PubMed Web of Science ®Google Scholar
• Chukwu OA, Chukwu U, Lemoha C. Poor performance of medicines logistics and supply chain systems in a developing country context: lessons from Nigeria. J Pharm Health Serv Res. 2018;9(4):289–291.
   Google Scholar